Olema Pharmaceuticals Inc share price logo

Olema Pharmaceuticals Inc Share Price

NASDAQ: OLMA

Small Cap

$15.52

+0.17

(+1.11%)

as on

Olema Pharmaceuticals Inc Stock Performance

as on April 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $15.00
    $15.62
    downward going graph

    3.35%

    Downside

    0.64%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.89
    $36.26
    downward going graph

    74.94%

    Downside

    133.63%

    Upside

    downward going graph

Olema Pharmaceuticals Inc share price movements today

Previous Close
$15.35
Open
$15.38
Volume
652.4K
Day's Low - High
$15.00 - $15.62
52 Week Low - High
$3.89 - $36.26

Olema Pharmaceuticals Inc Historical Returns

1 Month Return
+ 10.19 %
3 Month Return
-39.16 %
1 Year Return
+ 200.98 %
3 Year Return
+ 279.95 %
5 Year Return
-50.55 %

Olema Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Olema Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-2.2875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-168.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-36.61%

Olema Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Olema Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Olema Pharmaceuticals Inc image
Olema Pharmaceuticals Inc
BUY$1.4B-50.55%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.4B129.51%133.38.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.3B99.68%28.5732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.3BNA121.875.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B56.77%17.9931.41%

Stock Returns calculator for Olema Pharmaceuticals Inc Stock including INR - Dollar returns

The Olema Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Olema Pharmaceuticals Inc investment value today

Current value as on today

₹3,36,065

Returns

₹2,36,065

(+236.06%)

Returns from Olema Pharmaceuticals Inc Stock

₹2,04,314 (+204.31%)

Dollar Impact

₹31,751 (+31.75%)

Analyst Recommendation on Olema Pharmaceuticals Inc Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Olema Pharmaceuticals Inc. Average target price of $43

Olema Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Olema Pharmaceuticals Inc.

What analysts predicted

63.91%UPSIDE

Target Price

$43

Current Price

$15.52

Analyzed by

16 Analysts

Target

$43.00

Olema Pharmaceuticals Inc target price $43, a slight upside of 63.91% compared to current price of $15.52. According to 16 analysts rating.

Olema Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Olema Pharmaceuticals Inc Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-59% versus previous 30 day period

Olema Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
1
-
-
-
0
-
-
-
-
Gross Profit
0
1
0
0
0
0
0
-
-
0
Operating Income
-23
-30
-34
-33
-37
-36
-34
-47
-45
-50
EBITDA
-23
-30
-34
-33
-37
-36
-34
-47
-42
-49
Interest Expense
-
1
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-21
-26
-30
-30
-34
-33
-30
-43
-42
-46
Income Tax Expense
-1
4
-3
-
-
3
-
-
-
-
Net Income
-21
-26
-30
-30
-34
-33
-30
-43
-42
-46
Net Profit Margin
0.00%
-1421.02%
0.00%
0.00%
0.00%
-9221.70%
0.00%
0.00%
0.00%
0.00%

Olema Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-1
-1
0
0
-
Operating Income
-2
-4
-21
-71
-106
-104
-142
-178
EBITDA
-2
-4
-21
-71
-106
-104
-141
-178
Interest Expense
0
-
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-2
-4
-22
-71
-104
-96
-129
-162
Income Tax Expense
0
0
0
0
-2
-
0
-
Net Income
-2
-4
-22
-71
-102
-96
-129
-162
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Olema Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-26
-30
-30
-34
-33
-30
-43
-42
-46
Operating Cash Flow
-18
-23
-27
-27
-26
-43
-29
-34
-38
Investing Cash Flow
-30
-20
-4
45
-114
-45
34
17
-162
Financing Cash Flow
0
8
15
0
244
0
-2
0
213
Change in Cash
-48
-34
-16
18
103
-88
1
-17
13

Olema Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-22
-71
-104
-96
-129
-162
Operating Cash Flow
-3
-19
-50
-82
-83
-104
-146
Investing Cash Flow
0
0
-275
91
-4
-93
-155
Financing Cash Flow
358
358
1
0
133
268
211
Change in Cash
-3
338
-324
9
44
70
-91

Global Institutional Holdings in Olema Pharmaceuticals Inc

Funds
Holdings
Dimensional Fund Advisors, Inc.
1.76%
Vestal Point Capital LP
1.89%
Woodline Partners LP
1.7%
Defilade Capital Management, L.P.
1.42%
Citadel Advisors Llc
1.38%
See all

Olema Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 09 March

    Mon, 09:52 PM

    -

    Olema Pharmaceuticals shares fell 20.46% after Roche's trial results failed to meet primary objectives.

Insights on Olema Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, OLMA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, OLMA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, OLMA stock has moved down by -39.2%

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic ER-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, a mechanistic target of rapamycin inhibitor, and a CDK4 inhibitor that is in Phase 1b/2 clinical trial for the treatment of ER+/HER2- advanced or metastatic breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 which is in Phase 1 clinical trials for patients with breast and other solid tumor cancers. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
OrganisationOlema Pharmaceuticals Inc
Headquarters780 Brannan Street, San Francisco, CA, United States, 94103
IndustryBiotechnology
CEODr. Sean P. Bohen M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Olema Pharmaceuticals Inc

Name

Title

Mr. Shane William Charles Kovacs M.B.A.

Consultant

Dr. Naseem Zojwalla M.D.

Chief Medical Officer

Ms. Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

Dr. David C. Myles Ph.D.

Chief Discovery & Non-Clinical Development Officer

Dr. Mark Shilkrut M.D., Ph.D.

Senior Vice President of Clinical Development

Dr. Kamesh Kuchimanchi Ph.D.

Senior Vice President of Regulatory Affairs & Quality Assurance

Dr. Sean P. Bohen M.D., Ph.D.

President, CEO, Interim Principal Financial Officer & Director

Ms. Courtney O'Konek

Vice President of Corporate Communications

Ms. Julie Dexter

Senior VP & Head of People

Mr. Richard Hernandez

Senior Vice President of Clinical Development Operations

FAQs

What is Olema Pharmaceuticals Inc share price today?

Olema Pharmaceuticals Inc share price today is $15.52 as on at the close of the market. Olema Pharmaceuticals Inc share today touched a day high of $15.62 and a low of $15.

What is the 52 week high and 52 week low for Olema Pharmaceuticals Inc share?

Olema Pharmaceuticals Inc share touched a 52 week high of $36.26 on and a 52 week low of $3.89 on . Olema Pharmaceuticals Inc stock price today i.e. is closed at $15.52,which is 57.20% down from its 52 week high and 298.97% up from its 52 week low.

What is Olema Pharmaceuticals Inc's market capitalisation today?

Olema Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Olema Pharmaceuticals Inc Stock (OLMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Olema Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Olema Pharmaceuticals Inc Shares that will get you 0.0966 shares as per Olema Pharmaceuticals Inc share price of $15.52 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Olema Pharmaceuticals Inc Stock (OLMA) from India?

Indian investors can start investing in Olema Pharmaceuticals Inc (OLMA) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Olema Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Olema Pharmaceuticals Inc share’s latest price of $15.52 as on April 25, 2026 at 1:29 am IST, you will get 0.6443 shares of Olema Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Olema Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Olema Pharmaceuticals Inc stock has given -50.55% share price returns and 25.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?